Suggestions
Allan Gobbs
Venture Investor, Deeptech Entrepreneur & Educator | 5 IPOs & 4 M&As | Chairman | Speaker Feat. In WSJ, FT, WaPo, The New Yorker
Allan Gobbs is a prominent Venture Capitalist with a strong background in Private Equity, Asset Management, Corporate Finance, M&A, IPO, and Strategic Advisory. His specialized areas include Life Sciences/Healthtech, Web3/Metaverse, and Creative Industries/New Media. He is deeply passionate about causes such as Classical Music, Contemporary Art, Oncology, and Rare Diseases.
Currently serving as a Co-Founder and Managing Partner at ATEM Capital, located in New York, Allan has been instrumental in securing a $760 million strategic partnership with Domain Associates, a renowned biotech venture group in the US. His notable investments have yielded exceptional returns, with successes like Atea Pharmaceuticals demonstrating a 30x cash-on-cash return during its IPO.
Demystifying traditional education, Allan launched GATELEAD, the Global Advanced Technology Entrepreneurship and Leadership School, which focuses on empowering teams engaged in corporate innovations or pioneering ventures within Life Sciences, Medtech/Diagnostics & Healthtech.
Prior to his current roles, Allan held the position of Vice President at Barclays Capital, concentrating on Energy & Utilities, Telecoms, and High Tech sectors. His finance career began at Dresdner Kleinwort, where he advised on significant M&A and capital markets transactions exceeding $20 billion in value.
An esteemed member of various boards, Allan Gobbs has contributed to the success of companies like Marinus, Tobira, Neothetics, OcuNexus, Adastra, NovaDigm, Atea, Revision Optics, Syndax, and Miramar Labs through his strategic insights and guidance.
Education has been a cornerstone of Allan's professional development, with studies ranging from Harvard Business School to INSEAD, CFA Institute, and various cutting-edge courses in biology and immunology from prestigious institutions like Osaka University, Rice University, MIT, and Johns Hopkins University.
Throughout his career, Allan has been actively involved in multiple organizations, holding key roles in companies like VirryHealth, Walden Biosciences, YCare, PGxAI, Deka Biosciences, and more. Additionally, he has served as a mentor at healthtech incubators and been part of esteemed associations like the Forbes Business Council and the Private Directors Association.
A celebrated figure in the world of Venture Capital and deep technology entrepreneurship, Allan Gobbs continues to make significant contributions to the industry with his astute insights, strategic acumen, and unwavering commitment to fostering innovation and success.